With more than a decade of consistent growth, the Association of American Cancer Institutes (AACI) Clinical Research Innovation (CRI) program has expanded from an initiative into a permanent fixture among cancer center clinical trials professionals. To recognize CRI’s pioneering efforts to develop and disseminate best practices for cancer clinical trials, AACI renamed the program “Clinical Research Innovation” in 2018. CRI’s forward momentum also drives the programming of the 11th Annual AACI CRI Meeting, titled “Strategies to Maximize Innovation and Advance Cancer Clinical Research.”
The CRI annual meeting program aligns with AACI's strategic goal of stimulating cancer center interactions to maximize resources by creating opportunities for peer-to-peer networking and collaboration. CRI participants fill a variety of leadership roles and possess a comprehensive understanding of the clinical trials system.